Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth
Status:
Active, not recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine whether treatment of pregnant Malawian women with
repeated doses of sulfadoxine-pyrimethamine and azithromycin antibiotics will prevent preterm
deliveries and result in other health benefits both for the mother and the foetus/newborn.
Phase:
Phase 3
Details
Lead Sponsor:
Tampere University University of Tampere
Collaborators:
Academy of Finland Foundation for Paediatric Research, Finland
Treatments:
Azithromycin Fanasil, pyrimethamine drug combination Pyrimethamine Sulfadoxine